Women

A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

Providence Cancer Institute presents a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.

Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.

Sprawling multi-million dollar facility in Orange County is a one-stop location to access full-suite of women’s health, mother-baby services and more

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

At Providence, we recognize the importance of providing holistic care and comprehensive prenatal, labor and delivery, and postpartum support for Black birthing parents and babies.

In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.

Learn the truth about endometriosis, including the symptoms, treatments and more in this comprehensive guide from Providence.

Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).

Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.

Did you know that women in their 40s are at a higher risk of developing certain health conditions, such as breast cancer, diabetes, high blood pressure, and osteoporosis?

New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.